Therapeutic Class
ADCs flying high amid surge in M&A, licensing, and CDMO investment
Therapeutic ClassADCs flying high amid surge in M&A, licensing, and CDMO investmentADCs flying high amid surge in M&A, licensing, and CDMO investment
Through a string of molecule licensing deals, investments in tech, and ‘that’ Seagen bid, 2023 really has seen an ADC renaissance.